$PALI
PALISADE BIO, INC.

2019 Q1 Form 10-K Financial Statement

#000117184319001917 Filed on March 22, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 2017 Q4
Revenue $2.500K $260.0K $250.0K
YoY Change 0.0% 0.0% 2400.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $940.0K $4.560M $1.300M
YoY Change -20.34% -16.64% -20.25%
% of Gross Profit
Research & Development $1.514M $3.960M $1.230M
YoY Change 29.5% -51.09% -69.48%
% of Gross Profit
Depreciation & Amortization $40.00K $84.00K $60.00K
YoY Change -42.86% -16.0% 0.0%
% of Gross Profit
Operating Expenses $2.459M $8.519M $2.520M
YoY Change 4.57% -37.21% -55.48%
Operating Profit -$2.457M -$8.259M
YoY Change 4.58% -37.93%
Interest Expense $2.017K $7.698K -$1.050M
YoY Change 5.05% -95.16% -488.89%
% of Operating Profit
Other Income/Expense, Net -$657.4K $3.335M $10.00K
YoY Change -425.42% -241.37% -200.0%
Pretax Income -$3.110M -$4.920M -$3.320M
YoY Change 44.65% -68.6% -38.52%
Income Tax
% Of Pretax Income
Net Earnings -$3.114M -$4.925M -$3.320M
YoY Change 45.04% -68.56% -38.52%
Net Earnings / Revenue -124559.68% -1894.08% -1328.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$20.73M -$37.85M -$25.54M
COMMON SHARES
Basic Shares Outstanding 18.21M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.010M $5.790M $11.67M
YoY Change -58.74% -50.39% -42.2%
Cash & Equivalents $4.005M $5.790M $6.675M
Short-Term Investments $0.00 $5.000M
Other Short-Term Assets $300.0K $360.0K $400.0K
YoY Change -14.29% -10.0% -38.46%
Inventory
Prepaid Expenses $295.4K $402.3K
Receivables $237.8K $290.0K $312.8K
Other Receivables $0.00 $70.00K $60.00K
Total Short-Term Assets $4.538M $6.510M $12.45M
YoY Change -55.54% -47.71% -40.45%
LONG-TERM ASSETS
Property, Plant & Equipment $75.67K $90.00K $172.9K
YoY Change -49.44% -47.06% -35.86%
Goodwill
YoY Change
Intangibles $738.4K $883.5K
YoY Change -12.02% -10.78%
Long-Term Investments
YoY Change
Other Assets $53.35K $20.00K $13.85K
YoY Change 195.62% 100.0% -11.55%
Total Long-Term Assets $867.4K $1.170M $1.436M
YoY Change -35.33% -18.18% -15.53%
TOTAL ASSETS
Total Short-Term Assets $4.538M $6.510M $12.45M
Total Long-Term Assets $867.4K $1.170M $1.436M
Total Assets $5.406M $7.680M $13.88M
YoY Change -53.2% -44.67% -38.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.080M $830.0K $880.0K
YoY Change -7.69% -5.68% -62.39%
Accrued Expenses $0.00 $420.0K
YoY Change -100.0% -50.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.210M $1.050M $1.515M
YoY Change -5.39% -30.46% -79.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $920.0K $580.0K $3.850M
YoY Change -74.86% -84.94% -2.28%
Total Long-Term Liabilities $920.0K $580.0K $3.850M
YoY Change -74.86% -84.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.210M $1.050M $1.515M
Total Long-Term Liabilities $920.0K $580.0K $3.850M
Total Liabilities $2.134M $1.630M $5.369M
YoY Change -56.83% -69.65% -52.37%
SHAREHOLDERS EQUITY
Retained Earnings -$216.7M -$208.7M
YoY Change 2.79% 8.12%
Common Stock $182.1K $151.6K
YoY Change 20.09% 37.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.272M $6.050M $8.515M
YoY Change
Total Liabilities & Shareholders Equity $5.406M $7.680M $13.88M
YoY Change -53.2% -44.67% -38.58%

Cashflow Statement

Concept 2019 Q1 2018 2017 Q4
OPERATING ACTIVITIES
Net Income -$3.114M -$4.925M -$3.320M
YoY Change 45.04% -68.56% -38.52%
Depreciation, Depletion And Amortization $40.00K $84.00K $60.00K
YoY Change -42.86% -16.0% 0.0%
Cash From Operating Activities -$1.666M -$7.692M -$2.290M
YoY Change -9.8% -42.66% -43.87%
INVESTING ACTIVITIES
Capital Expenditures $1.714K $0.00
YoY Change -84.97% -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $5.000M $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities $4.998M $0.00
YoY Change -5414.72% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -117.0K 1.814M -100.0K
YoY Change 12.25% -63.65% -100.54%
NET CHANGE
Cash From Operating Activities -1.666M -7.692M -2.290M
Cash From Investing Activities 4.998M 0.000
Cash From Financing Activities -117.0K 1.814M -100.0K
Net Change In Cash -1.783M -879.9K -2.390M
YoY Change -158.48% -89.67% -125.11%
FREE CASH FLOW
Cash From Operating Activities -$1.666M -$7.692M -$2.290M
Capital Expenditures $1.714K $0.00
Free Cash Flow -$7.694M -$2.290M
YoY Change -42.7% -43.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 cur Accounts Payable And Accrued Expenses Excluding Accrued Bonuses
AccountsPayableAndAccruedExpensesExcludingAccruedBonuses
832564
CY2017Q4 cur Accounts Payable And Accrued Expenses Excluding Accrued Bonuses
AccountsPayableAndAccruedExpensesExcludingAccruedBonuses
875065
CY2018 cur Cost Reimbursements From Sbir Grant As Offset To Research And Development Expenses
CostReimbursementsFromSBIRGrantAsOffsetToResearchAndDevelopmentExpenses
538000
CY2017 cur Cost Reimbursements From Sbir Grant As Offset To Research And Development Expenses
CostReimbursementsFromSBIRGrantAsOffsetToResearchAndDevelopmentExpenses
41000
CY2018 cur Effective Income Tax Rate Reconciliation Change In Fair Value Of Liability Classified Warrants Percent
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfLiabilityClassifiedWarrantsPercent
-0.173
CY2017 cur Effective Income Tax Rate Reconciliation Change In Fair Value Of Liability Classified Warrants Percent
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfLiabilityClassifiedWarrantsPercent
-0.036
CY2018 cur Expenses Related To Issuance Of Derivative Instrument
ExpensesRelatedToIssuanceOfDerivativeInstrument
CY2017 cur Expenses Related To Issuance Of Derivative Instrument
ExpensesRelatedToIssuanceOfDerivativeInstrument
242676
CY2018 cur Expenses Related To The Inducement Of Warrants
ExpensesRelatedToTheInducementOfWarrants
CY2017 cur Expenses Related To The Inducement Of Warrants
ExpensesRelatedToTheInducementOfWarrants
563744
CY2018 cur Fees Related To Issuance Of Derivative Instrument And Other Expenses
FeesRelatedToIssuanceOfDerivativeInstrumentAndOtherExpenses
5391
CY2017 cur Fees Related To Issuance Of Derivative Instrument And Other Expenses
FeesRelatedToIssuanceOfDerivativeInstrumentAndOtherExpenses
799907
CY2018Q4 cur Operating Leases Future Minimum Payments Due After Four Years
OperatingLeasesFutureMinimumPaymentsDueAfterFourYears
CY2018 cur Proceeds From Exercise Of Stock Purchase Warrants Net Of Issuance Costs
ProceedsFromExerciseOfStockPurchaseWarrantsNetOfIssuanceCosts
CY2017 cur Proceeds From Exercise Of Stock Purchase Warrants Net Of Issuance Costs
ProceedsFromExerciseOfStockPurchaseWarrantsNetOfIssuanceCosts
3225176
CY2018 cur Proceeds From Issuance Or Sale Of Equity Net Of Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfIssuanceCosts
1828000
CY2017 cur Proceeds From Issuance Or Sale Of Equity Net Of Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfIssuanceCosts
5510840
CY2017 cur Stock And Warrants Issued During Period From Capital Raises Value Net
StockAndWarrantsIssuedDuringPeriodFromCapitalRaisesValueNet
3269667
CY2018 cur Stock And Warrants Issued During Period From Capital Raises Value Net
StockAndWarrantsIssuedDuringPeriodFromCapitalRaisesValueNet
1828000
CY2017 cur Stock Issued During Period Value From Warrants Exercised
StockIssuedDuringPeriodValueFromWarrantsExercised
7811977
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
CY2018 dei Document Type
DocumentType
10-K
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18205060
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018Q2 dei Entity Public Float
EntityPublicFloat
14056602
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
294057
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
312802
CY2018Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
CY2017Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
418625
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
902260
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
821925
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-413
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2631
CY2018 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P9Y109D
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
219481805
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
217050174
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1769964
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
634082
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
634082
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1769964
CY2018 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
CY2017 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
59781
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
102000
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
189000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12600000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10200000
CY2017 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2018 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2018Q4 us-gaap Assets
Assets
7684450
CY2017Q4 us-gaap Assets
Assets
13884456
CY2018Q4 us-gaap Assets Current
AssetsCurrent
6508393
CY2017Q4 us-gaap Assets Current
AssetsCurrent
12448799
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6674940
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15194949
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5787110
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-887830
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-8520009
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18205060
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15160014
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18205060
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15160014
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
182051
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
151600
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4927661
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15667257
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
7726
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
17837120
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2741660
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
19254602
CY2018 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
2741660
CY2017 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-19254602
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-2749386
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1417482
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
46229259
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
43487600
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
42580533
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
185803
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
289208
CY2018 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
3269148
CY2017 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1470174
CY2018Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
583734
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.539
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.096
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.05
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.041
CY2017Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3852882
CY2018Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
63938
CY2017Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
58784
CY2018 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y328D
CY2018Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
179000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
35610806
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
1005255
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
1112286
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2643471
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
6764508
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
46229259
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
43487600
CY2018 us-gaap Depreciation
Depreciation
84000
CY2017 us-gaap Depreciation
Depreciation
100000
CY2018Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
298238
CY2017Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
365456
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.20
CY2018 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-7930
CY2017 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-579
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.557
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1.229
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.663
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
1.55
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1242900
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1145095
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
80000
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
80000
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
80000
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
80000
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
80000
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2006443
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2028557
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
763543
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
883462
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-18342
CY2017 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-8128
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4559265
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5471010
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-36991
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1522917
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18745
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
302311
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-418625
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-434338
CY2018 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-62064
CY2017 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-53081
CY2018 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
11490
CY2017 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-230189
CY2018 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
3991
CY2017 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1855
CY2018 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1876
CY2017 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-16333
CY2018 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-32303
CY2017 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-297298
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
763543
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
883462
CY2018 us-gaap Interest Expense
InterestExpense
7698
CY2017 us-gaap Interest Expense
InterestExpense
159066
CY2018 us-gaap Interest Paid Net
InterestPaidNet
7698
CY2017 us-gaap Interest Paid Net
InterestPaidNet
118257
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
78780
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
70269
CY2018 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
164000
CY2017 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
161000
CY2018Q4 us-gaap Liabilities
Liabilities
1634900
CY2017Q4 us-gaap Liabilities
Liabilities
5369327
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7684450
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13884456
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1051166
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1514569
CY2018Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
CY2017Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
1876
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1814233
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4990778
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4998286
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-94046
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7692419
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13416162
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-15665983
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-4924617
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3334839
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2358878
CY2018 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2018 us-gaap Operating Expenses
OperatingExpenses
8519456
CY2017 us-gaap Operating Expenses
OperatingExpenses
13567105
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-8259456
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-13307105
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
115000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
115000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
156000000
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
146400000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23965
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13853
CY2017 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1274
CY2018 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3044
CY2018 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3044
CY2017 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1274
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
218602
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
220879
CY2018 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
CY2017 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
82645
CY2018 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
CY2017 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
5000000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1714
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11401
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
10000
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
10000
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
363288
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
402273
CY2018 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
5000000
CY2017 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
5000000
CY2018 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
349578
CY2017 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
346863
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-213623893
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-208699276
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
992571
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
994811
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
90311
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
172886
CY2018 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
CY2017 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3765568
CY2018 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
363345
CY2017 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
326533
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3960191
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8096095
CY2018 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
260000
CY2017 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
260000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
7077374
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
634082
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
1769964
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
10800000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1166127
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
14.59
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
750055
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
488640
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.47
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.34
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
108000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1894077
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1632662
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.76
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.78
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
27.19
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.13
CY2018Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1632662
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y146D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y36D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y255D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
205000
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
302000
CY2018Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
10.78
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
CY2017Q4 us-gaap Short Term Investments
ShortTermInvestments
5000000
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
11330778
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
8515129
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
6049550
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0; background-color: white"><div style="display: inline; background-color: white"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0; background-color: white"><div style="display: inline; background-color: white">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The consolidated financial statements include significant estimates for the expected economic life and value of our licensed technology and related patents, our net operating loss and related valuation allowance for tax purposes, the fair value of our liability classified warrants and our share-based compensation related to employees and directors, consultants and advisors, among other things. Because of the use of estimates inherent in the financial reporting process, actual results could differ significantly from those estimates.</div></div></div></div></div></div></div></div></div></div>
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15156925
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13064422

Files In Submission

Name View Source Status
0001171843-19-001917-index-headers.html Edgar Link pending
0001171843-19-001917-index.html Edgar Link pending
0001171843-19-001917.txt Edgar Link pending
0001171843-19-001917-xbrl.zip Edgar Link pending
cur-20181231.xml Edgar Link completed
cur-20181231.xsd Edgar Link pending
cur-20181231_cal.xml Edgar Link unprocessable
cur-20181231_def.xml Edgar Link unprocessable
cur-20181231_lab.xml Edgar Link unprocessable
cur-20181231_pre.xml Edgar Link unprocessable
exh_2301.htm Edgar Link pending
exh_311.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_431.htm Edgar Link pending
f10k_032919p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
graph_1.jpg Edgar Link pending
graph_2.jpg Edgar Link pending
graph_3.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending